Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| LGND (Ligand Pharmaceuticals Incorporated) | 24.77% | 127.27% | 49.22% | 4.99% | 2.35% | 19.44% | 5.54% | … | … |
Data as of 06/04/2026, Common starting date is 11/18/1992
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| LGND (Ligand Pharmaceuticals Incorporated) | 11/18/1992 | 06/04/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 0.53 | 127.27 | 49.22 | 4.99 | 2.35 | 19.44 | 5.54 | … | … | 24.77 | 82.76 | 52.88 | 6.92 | -56.75 | 55.31 | -4.64 | -23.15 | -0.90 | 34.76 | -6.28 | 103.76 | 1.16 | 153.62 | 74.73 | 33.07 | -31.49 | -20.80 | -43.27 | -41.17 | -1.79 | -4.21 | -20.76 | 173.56 | -70.00 | 27.86 | 8.74 | 10.75 | -9.71 | -13.45 | 38.37 | 30.30 | -29.79 | 11.90 | -14.29 |
| Sharpe Ratio | NA | 3.46 | 1.14 | 0.03 | 0.00 | NA | NA | … | … | 1.47 | 2.34 | 1.04 | 0.08 | -0.79 | 0.97 | -0.08 | -0.54 | -0.05 | 1.44 | -0.17 | 2.22 | 0.02 | 3.33 | 1.62 | 0.60 | -0.72 | -0.31 | -0.38 | -0.95 | -0.15 | -0.10 | -0.29 | 2.84 | -0.80 | 0.38 | 0.05 | 0.11 | -0.18 | -0.36 | 0.60 | 0.40 | -0.46 | 0.13 | -1.31 |
| Standard Deviation(%) | NA | 36.72 | 38.81 | 48.46 | 47.68 | NA | NA | … | … | 42.39 | 34.88 | 44.89 | 34.95 | 73.91 | 56.90 | 62.83 | 45.20 | 40.26 | 23.85 | 38.38 | 46.63 | 49.84 | 46.08 | 46.62 | 54.85 | 44.09 | 68.34 | 116.71 | 46.72 | 34.73 | 65.72 | 74.14 | 60.81 | 88.72 | 67.64 | 85.42 | 69.78 | 71.23 | 46.72 | 58.06 | 66.64 | 71.39 | 75.44 | 57.87 |
| Draw Down(%) | NA | 14.07 | 37.25 | 81.35 | 88.73 | NA | NA | … | … | 14.07 | 20.91 | 23.17 | 37.51 | 65.83 | 52.59 | 41.26 | 39.46 | 53.24 | 12.70 | 34.19 | 26.20 | 46.77 | 21.24 | 37.01 | 33.61 | 36.48 | 47.30 | 73.87 | 59.96 | 42.39 | 59.19 | 67.28 | 35.91 | 75.44 | 46.78 | 61.30 | 52.91 | 64.34 | 45.11 | 40.79 | 34.33 | 56.14 | 28.57 | 26.61 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.12 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.94 | 0.00 | 0.00 | 22.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/04/2026, Common starting date is 11/18/1992
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| LGND (Ligand Pharmaceuticals Incorporated) |
-43.36%
Jan 2007 – Jan 2010 |
-32.88%
Sep 2018 – Sep 2023 |
-19.96%
Feb 2000 – Feb 2010 |
-12.17%
May 1996 – May 2011 |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| LGND (Ligand Pharmaceuticals Incorporated) |
92.38%
Jan 2011 – Jan 2014 |
66.22%
Nov 2010 – Nov 2015 |
35.78%
Jan 2011 – Jan 2021 |
19.80%
Nov 2010 – Nov 2025 |
Annualized Rolling Returns Comparison Chart